rethinkPeptides Search
Menu
Study breakdown

Short Peptide Hormones as Powerful Anti-Autoimmune Therapies: VIP, Alpha-MSH, CGRP, and Cortistatin

evidence
The takeaway

Short peptide hormones (VIP, alpha-MSH/KPV, CGRP, cortistatin) demonstrate potent anti-autoimmune activity through Treg generation, dendritic cell tolerization, and inflammatory cytokine suppression — natural immunosuppressants.

Key finding

Short peptide hormones (VIP, alpha-MSH/KPV, CGRP, cortistatin) demonstrate potent anti-autoimmune activity through Treg generation, dendritic cell tol

What the researchers found

Short peptide hormones (VIP, alpha-MSH/KPV, CGRP, cortistatin) demonstrate potent anti-autoimmune activity through Treg generation, dendritic cell tolerization, and inflammatory cytokine suppression — natural immunosuppressants.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2009.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Short Peptide Hormones as Powerful Anti-Autoimmune Therapies: VIP, Alpha-MSH, CGRP, and Cortistatin
What was found?
Short peptide hormones (VIP, alpha-MSH/KPV, CGRP, cortistatin) demonstrate potent anti-autoimmune activity through Treg generation, dendritic cell tolerization, and inflammatory cytokine suppression — natural immunosuppressants.

Read the original research

Small but powerful: short peptide hormones and their role in autoimmune inflammation.

Journal of neuroimmunology, 217(1-2), 1-7

Citation

Lühder, F; Lee, D H; Gold, R; Stegbauer, J; Linker, R A. (2009). Small but powerful: short peptide hormones and their role in autoimmune inflammation.. Journal of neuroimmunology, 217(1-2), 1-7. https://doi.org/10.1016/j.jneuroim.2009.08.008